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Common origin of methylenedioxy 
ring degradation and 
demethylation in bacteria
Hisashi Takeda1, Kazuki Ishikawa1, Hinaka Yoshida1, Daisuke Kasai2, Daigo Wakana1, Masao 
Fukuda2, Fumihiko Sato  3 & Tomoo Hosoe1
Plants produce many specific secondary metabolites as a response to environmental stress, 
especially biological stress. These compounds show strong biological activities and high stability 
against degradation by microbes and animals. Berberine, a benzylisoquinoline alkaloid, is found 
in many plant species and has strong antimicrobial activity, and is often included in traditional 
herbal medicines. We previously investigated how berberine is degraded in nature and we isolated 
two berberine-utilizing bacteria. In this study, we characterized the gene encoding the enzyme 
that degrades the 2,3-methylenedioxy ring of berberine; this ring is important for its activity and 
stability. Further characterization of several other berberine-utilizing bacteria and the genes encoding 
key demethylenation enzymes revealed that these enzymes are tetrahydrofolate dependent and 
similar to demethylation enzymes such as GcvT. Because the degradation of O-methyl groups or the 
methylenedioxy ring in phenolic compounds such as lignin, lignan and many other natural products, 
including berberine, is the key step for the catabolism of these compounds, our discovery reveals the 
common origin of the catabolism of these stable chemicals in bacteria.
Plants produce many secondary metabolites to respond to environmental stress, especially biological stress. These 
compounds have strong biological activities and high stability against degradation by microbes and animals. 
Berberine (BBR) is a benzylisoquinoline alkaloid that is produced by various higher plants, such as Coptis japon-
ica, Berberis fremontii and Mahonia aquifolium1, and shows strong antimicrobial and chemical defense activities2. 
BBR was also used as an antidiarrheal in ancient times, and interest in its use toward improving intestinal micro-
flora is increasing3, 4. Although few studies have characterized the structure-activity relationship of protoberber-
ine alkaloids, chemicals with a methylenedioxy ring, such as BBR, tend to demonstrate more activity than those 
with dimethoxy or hydroxy groups, such as palmatine5, 6.
The metabolism of BBR has been mainly investigated in mammals. CYP2D6, CYP1A2 and CYP3A4 are 
responsible for metabolizing BBR to demethyleneberberine (D-BBR) in human liver microsomes7. Interestingly, 
BBR was not metabolized by the intestinal bacteria of humans and rats in anaerobic conditions8, 9. Liquid
chromatography/time-of-flight mass spectrometry analysis of bile, plasma and urine in rats revealed the pres-
ence of BBR metabolites, including thalifendine, berberrubine, D-BBR, jatrorrhizine, palmatine, columbamine, 
3,9-demethyl-palmatine, hydroxylated BBR and hydroxylated D-BBR; BBR was converted into sulfate and glucu-
ronic acid conjugates for excretion10.
There is currently a new opportunity to study the environmental fate of BBR: two bacteria, Sphingobium 
sp. strain BD3100 and Rhodococcus sp. strain BD7100, that utilize BBR as their sole carbon source were 
isolated from the sludge of a berberine-producing factory11. The formation of demethyleneberber-
ine (D-BBR), a common metabolite of BBR, was detected in both strains, whereas 11-hydroxyberberine 
(H-BBR) and 11-hydroxydemethyleneberberine (HD-BBR) were unique to BD310011, and 2-hydroxy-3,4
-dimethoxybenzeneacetic acid (HDBA) was unique to BD710012. This result suggests that demethylation is the 
key step in the catabolism of BBR in these bacteria (Fig. 1).
To isolate the BBR-demethylenation enzyme from the bacteria, we used a transposon tagging method; the 
function of a gene, designated brdA, was confirmed using recombinant protein that was produced in E. coli. 
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Furthermore, other BBR-degraders, Arthrobacter sp. strain GBD-1 and Burkholderia sp. strain CJ1, were isolated, 
and their BrdA homologs were characterized. All BrdA homologs showed distinct enzyme activity that converts 
BBR to D-BBR and high sequence similarity to the bacterial tetrahydrofolate (THF)-dependent aminomethyl-
transferase of the glycine cleavage system’s T-protein. Because of the high sequence similarity of the demethylase 
and demethylenases isolated here, we discuss the common origin of these THF-dependent enzymes that degrade 
plant-specific secondary metabolites in bacterial cells.
Results
Isolation and characterization of brdA. To isolate the genes that are involved in the degradation of BBR, 
a plasmid for transposon tagging, pTNR-TA, was introduced into BD7100, and some mutant strains that do not 
exhibit BBR degradation, such as T140, were isolated (Fig. 2a). The transposon insertion site in TA140 was ampli-
fied by inverse PCR, sequenced and identified by a BLAST search against the genome sequence of BD7100. The 
insertion of the transposon was found in the CDS6194 gene, which has been annotated as a vanillate/3-O-methyl-
gallate O-demethylase in BD7100.
The amino acid sequence of CDS6194 has 44–50% identity with the T-protein of the glycine cleavage sys-
tem (GcvT), which is expected to function as a THF-dependent aminomethyltransferase in various bacte-
ria (Supplementary Table 1). In addition, the amino acid sequence of CDS6194 has 26.7% identity with the 
THF-dependent enzymes LigM (vanillate demethylase, accession: BAD61059) and DesA (syringate demethylase, 
accession: BAC79257), which are reported to function in lignin degradation by Sphingobium paucimobilis strain 
SYK-613, 14. The sequence is also 27% identical to the THF-dependent enzyme SesA (accession: LC101493), a 
sesamin (a lignan) demethylenase, which was reported in the sesamin-metabolizing bacterium Sinomonas sp. 
no. 2215. Reverse transcription PCR (RT-PCR) analysis of the CDS6194 gene in BD7100 (Supplementary Fig. 1) 
indicated that its transcription only occurs in BD7100 cells that are grown in LB medium containing BBR, which 
suggests the active involvement of CDS6194 in the degradation of BBR in BD7100.
The function of CDS6194 was further confirmed using resting-cell assays of TA140 and comparing the results 
to those of BD7100 (Supplementary Fig. 2). When the resting cells were grown in LB medium containing BBR 
(BBR-induced cells), BBR was almost completely degraded within 1.5 h; the production of D-BBR was observed 
in BD7100 cells, but TA140 did not degrade BBR or produce D-BBR. Thus, we named the CDS6194 gene ‘brdA’ 
(berberine degrading gene A).
To confirm the function of brdA, TA140 cells were complemented with brdA by using pTQbrdA and the 
growth were observed in the minimal medium containing BBR or D-BBR (Fig. 2b). Whereas TA140 cells that 
contained pTip-QC1 (the vector control) did not grow on BBR, TA140 cells containing pTQbrdA demonstrated 
the ability to grow on BBR. However, both BD7100 and TA140 were able to grow on D-BBR, suggesting that BrdA 
is essential for the conversion of BBR to D-BBR.
To determine the enzymatic activity of BrdA in BD7100, BrdA with a 6xHis-tag at its N-terminus (pEbrdA) 
was overexpressed in E. coli BL21 (DE3). Crude-extract assays with BrdA degraded 24% of the BBR within 60 min 
(Fig. 2c), whereas the negative control harboring pET-28a (+) showed no BBR degradation. The His-BrdA that 
was purified from the crude E. coli extract (Fig. 2d) did not convert BBR to D-BBR, but the addition of THF to 
the purified BrdA activated the conversion of BBR to D-BBR. This result indicates that BrdA is a THF-dependent 
enzyme and cleaves the methylenedioxy ring of BBR by transferring the methylene residue to THF.
Isolation of new BBR-utilizing bacteria. Because D-BBR is a common metabolite of BBR that is found 
in both BD7100 and BD310011, 12, other BBR-utilizing bacteria were isolated to investigate the significance of 
Figure 1. The BBR metabolites and deduced degradation pathway in BD3100 and BD7100. The BBR 
metabolites identified in BD7100 and BD3100 are boxed by a double line (with a filled background) and a single 
line, respectively. The thick arrow indicates demethylenation at the 2,3-methylenedioxy ring of BBR, which was 
a focus of this study. The dotted arrows indicate the deduced degradation pathway.
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demethylenation enzymes in BBR degradation in bacteria. Two BBR-degrading strains that could utilize BBR as a 
sole carbon source, named GBD-1 and CJ1, were isolated. The 16 S rRNA nucleotide sequences of GBD-1 and CJ1 
had high identity with Gram-positive bacteria of the genus Arthrobacter and Gram-negative bacteria of the genus 
Burkholderia, respectively. Phylogenetic trees of each BBR-degrader are shown in Supplementary Figs 3 and 4.
brdA homologs in BBR-utilizing bacteria. Detection of D-BBR in GBD-1 and CJ1 cultures confirmed 
that conversion of BBR to D-BBR was the initial step in BBR degradation in both strains (Supplementary Fig. 5), 
suggesting that GBD-1 and CJ1 each contain a gene that is similar to brdA. BrdA homologs were identified by the 
amino acid sequences based on the draft genome sequences of each strain (Table 1). The amino acid sequences 
Figure 2. Characterization of BrdA. (a) Growth of BD7100 and the transposon mutant TA140 for 5 days on LB 
medium containing 0.5 mM BBR. Compared with wild-type BD7100 strains, the BBR-derived yellow color in 
the medium did not disappear with TA140. (b) The growth of BD7100 and TA140 in minimal media containing 
BBR (circles) or D-BBR (triangles). The blue and orange lines indicate growth of BD7100 and TA140 harboring 
pTip-QC1 (vector control), respectively. The green line indicates growth of TA140 cells harboring pTQbrdA. 
Each value is the average of at least three measurements. The vertical lines indicate the standard deviations 
from the means. The addition of the brdA gene to the TA140 strain restored growth in BBR. (c) Crude-extract 
assay of BBR. The blue and orange lines indicate crude extracts of E. coli BL21 (DE3) harboring pET-28a and 
pEbrdA, respectively. Circles and triangles indicate concentrations of BBR and D-BBR, respectively. Each value 
is the average of at least three measurements. The vertical lines indicate the standard deviations from the means. 
(d) HPLC chromatograms (UV 280 nm) of the reaction at 10 min in the purified-enzyme assay. The D-BBR 
standard is shown at the bottom. The production of D-BBR is observed only in the presence of THF with His-
BrdA.
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CDS1201, CDS1137 and CDS4435 shared 29–30% identity with the BrdA of BD7100, whereas the amino acid 
sequences CDS7326, CDS7349 and CDS4430 shared 59–60% identity. The similarity and identity matrices of the 
amino acid sequence of BrdA are shown in Supplementary Table 2. The alignment of the amino acid sequences is 
shown in Supplementary Fig. 6. BD3100, GBD-1 and CJ1 each carried two orthologs of brdA.
RT-PCR analysis (Supplementary Fig. 7) indicated the presence of transcripts of every homolog except for 
CDS4335 when the organisms were grown in LB medium containing BBR. Thus, CDS1201, CDS1137, CDS4430, 
CDS7326 and CDS7349 were named as detailed in Table 1, and their enzymatic activities were examined with 
mutated cells and recombinant proteins.
As BD3100 has two homologous genes, brdA1 and brdA2, compared with the single brdA gene in BD7100, we 
examined the role of each gene in BBR degradation in BD3100 by constructing deletion mutants using homologs 
recombination. Whereas each mutant, designated BD∆brdA1 and BD∆brdA2, produced D-BBR in a resting-cell 
assay (Supplementary Fig. 8), the double-deletion mutant of brdA1 and brdA2, designated BD∆brdA12, did not 
produce D-BBR in the assay (Supplementary Fig. 9). These results indicate that both brdA1 and brdA2 of BD3100 
function in the cleavage of the methylenedioxy ring of BBR.
We constructed six plasmids (pE1201, pE1137, pE4430, pE4435, pE7326 and pE7349) and expressed each 
of the BrdA proteins in E. coli BL21 (DE3). Although most recombinant proteins were insoluble, several soluble 
proteins were detected and purified by Ni-NTA resin (Supplementary Fig. 10). The relative activities differed 
among BrdA homologs; BrdA of BD7100 and GBD-1 showed the highest BBR degradation activity (Table 1). 
These results clearly indicate that each BrdA protein functions as a BBR-demethylenation enzyme and cleaves the 
methylenedioxy ring of BBR, with the exception of the CDS4335 gene product.
Phylogenetic analysis of THF-dependent demethylase and demethylenase. We isolated four 
independent BBR-degrading bacteria, Rhodococcus sp. BD7100, Sphingobium sp. BD3100, Arthrobacter sp. 
GBD-1 and Burkholderia sp. CJ1, that belong to different genera. All BBR-degraders contained a brdA gene that 
they used to degrade BBR to D-BBR by demethylenation. Interestingly, BrdA proteins of these BBR-degrading 
bacteria are similar to the THF-dependent GcvT protein of various bacteria. Among the THF-dependent GcvT 
homologous enzymes, only four enzymes (SesA from Sinomonas sp. no. 22, DesA and LigM from Sphingobium 
paucimobilis SYK-6 and DmdA from Candidatus Pelagibacter ubique HTCC1062) have been characterized. 
DesA, LigM and DmdA catalyze the demethylation of syringic acid, vanillic acid and dimethylsulfoniopropion-
ate (DMSP), respectively13, 14, 16. SesA is a demethylenation enzyme, but its substrates are lignans such as sesamin, 
(−)-asarinin, sesaminol and sesamolin15 instead of alkaloids. Phylogenetic tree analysis of these THF-dependent 
demethylases and demethylenases showed that SesA and BrdA formed a clan of demethylenases, whereas DesA, 
LigM and DmdA formed another clan of demethylases that includes CDS4435 (Fig. 3). This result indicates the 
common origin of demethylenases and demethylases. This result also indicates that THF-dependent enzymes 
have key roles in the degradation of natural products with O-methylation or a methylenedioxy ring, such as lignin 
and lignan. BrdA is likely to be the predominant enzyme in the degradation of BBR.
We compared the amino acid sequences of BrdA homologs and SesA due to their reactive similarity as 
demethylenases. All the proton donor residues of SesA (R81, H82, R100, R179, and H225), which are expected 
to be used for demethylenation of the methylenedioxy ring of sesamin, were conserved in all the BrdA proteins 
except for R81of SesA (Supplementary Fig. 11). Among the residues that were predicted in SesA to make hydro-
gen bonds with THF (D95, E189, and Y221), E189 of SesA was conserved in all the BrdA proteins. D95 of SesA 
was conserved in BrdA of BD7100, BrdA of GBD-1, and BrdA2 of BD3100. Y221 was conserved in BrdA1 and 


















 6194 brdA 1,374 457 100 vanillate/3-O-methylgallate O-demethylase 10.9 ± 0.32*** 100
Sphingobium sp. BD3100
 1201 brdA1 1,392 463 34 vanillate/3-O-methylgallate O-demethylase 5.7 ± 0.35 52 ± 1.69
 1137 brdA2 1,371 456 33 vanillate/3-O-methylgallate O-demethylase 4.6 ± 0.17 42 ± 2.36
Arthrobacter sp. GBD-1
 4430 brdA 1,299 432 61 vanillate/3-O-methylgallate O-demethylase 10.4 ± 0.59 94 ± 5.35
 4435 — 1,431 476 33 vanillate/3-O-methylgallate O-demethylase 0.1 ± 0.03 1 ± 0.31
Burkholderia sp. CJ1
 7326 brdA1 1,290 429 61 vanillate/3-O-methylgallate O-demethylase 8.1 ± 0.26 74 ± 0.23
 7349 brdA2 1,317 438 60 vanillate/3-O-methylgallate O-demethylase 6.3 ± 0.21 58 ± 0.42
Table 1. Characterization of BrdA homologs in BBR-utilizing bacteria. *Amino acid sequence identity with 
BrdA of BD7100. **One unit of BBR-degrading activity was defined as degradation of 1 µM BBR per minute 
using 5 µg/ml of purified His-BrdA enzyme. Each value is the average of triplicate measurements. *** ±Indicate 
standard error of triplicate measurements.
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Discussion
In this study, we demonstrated that four species of BBR-degrading bacteria (two Gram-negative and two 
Gram-positive bacteria) harbor enzymes that cleave the methylenedioxy ring of BBR; these enzymes are similar 
to GcvT, the THF-dependent demethylenase that is involved in glycine metabolism. Cleavage at the methylene-
dioxy ring of sesamin in a Gram-positive bacterium, Sinomonas sp. no. 22, also occurred. However, demethylena-
tion enzymes that are involved in the cleavage of the methylenedioxy ring of BBR are different in mammals7–10, 
plants17 and bacteria. In eukaryotes, enzymatic reactions for BBR metabolism are oxidative reactions that use 
oxygen and the iron at the active site of their enzymes; both oxygen and iron are required for electron transfer 
with P450 reductase. Cytochrome P450 is responsible for the demethylenation of a methylenedioxy ring18–24. 
Conjugating BBR is the first step of the excretion process. By contrast, bacteria that have evolved to utilize BBR 
might have developed GcvT-like enzymes for demethylation and demethylenation without oxidation. We also 
found that all our isolated BBR-degraders performed demethylenation as the first step of BBR degradation. This 
sequential process suggests that demethylenation might be an important strategy for all BBR-utilizing bacteria 
before they proceed to the next step of the BBR degradation process. Our finding of the involvement of brdA 
orthologs in all BBR-degrading bacteria led to the discovery that the initial key reaction for BBR degradation is 
shared among all bacteria that are capable of BBR degradation. The bacterial demethylenation of methylenedioxy 
rings is derived from the C1 metabolism of the glycine cleavage system, which is responsible for fundamental 
metabolism that is common to both prokaryotes and eukaryotes.
Methods
Bacterial strains, plasmids and primers. The bacterial strains and plasmids used in this study are 
described in Supplementary Table 3. pK18mobsacB25 was obtained from the National BioResource Project (NIG, 
Figure 3. Phylogenetic tree of amino acid sequences in THF-dependent demethylenases and demethylases. 
The multiple alignments were generated by ClustalW, and phylogenetic trees were constructed using the 
neighbor-joining method. The amino acid sequences were obtained from NCBI. Enzymes: DmdA_DSS3, 
DMSP demethylase of Ruegeria pomeroyi strain DSS3 (accession: AAV95190); DmdA_HTCC1062, DMSP 
demethylase of Candidatus Pelagibacter ubique strain HTCC1062 (AAZ21068); DesA, syringate demethylase 
of S. paucimobilis SYK-6 (BAC79257); LigM, vanillate demethylase of SYK-6 (BAD61059); and SesA, sesamin 
demethylenase of Sinomonas sp. no. 22 (LC101493). The scale corresponds to a genetic distance of 0.05 
substitutions per position.
www.nature.com/scientificreports/
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Japan): E. coli. The rhodococcal transposon vector pTNR-TA26 and the expression vector pTip-QC127 were kind 
gifts from Dr. Tamura. The primers used in this study are listed in Supplementary Table 4.
Chemicals. Berberine sulfate was purchased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). 
Demethyleneberberine was chemically synthesized from BBR as described previously11, 12.
Media and culture conditions. Bacteria were grown in LB medium (10 g Bacto-tryptone, 5 g Bacto-yeast 
extract, and 5 g NaCl, in 1 liter), Pseudomonas medium28 and WM medium [1.7 g KH2PO4, 12.4 g Na2HPO4 · 
12H2O, 1.0 g (NH4)2SO4, 2.0 mg CaCO3, 1.4 mg ZnSO4 · 7H2O, 0.25 mg CuSO4 · 5H2O, 0.28 mg, CoSO4 · 7H2O, 
0.06 mg H3BO4, 100 mg MgSO4 · 7H2O, 0.95 mg FeSO4 · 7H2O and 10.7 mg MgO in 1 liter]. All cultures were incu-
bated at 30 °C, and liquid cultures were aerobically incubated with shaking at 180 rpm. Growth was monitored 
using an OD monitor (TAITECH, Tokyo, Japan) to measure the absorption at 600 nm.
Isolation of transposon mutants. One microgram of pTNR-TA was electroporated (voltage: 1200 V, 
capacitance: 25 µF, resistance: 800 Ω) in 0.1 ml of BD7100 cells in a chilled cuvette (1 mm gap) with a Gene Pulser 
II (Bio-Rad). One ml of SOC medium was then added to the cuvette immediately. The cell suspension was trans-
ferred to a sterile tube and heat shocked at 42 °C for 2 min. After incubation at 30 °C for 6 h, cells were spread 
onto LB agar plates containing 2 µg/ml thiostrepton. Each transformant was transferred to 0.2 ml of LB medium 
that contained 2 µg/ml thiostrepton and 0.5 mM BBR in a microtiter plate and incubated at 30 °C for five days. 
The transformants that did not bleach the yellow color derived from BBR were streaked onto 0.1x LB agar plates 
containing 2 µg/ml thiostrepton and 0.5 mM BBR.
Determination of transposon insertion sites. Total DNA from transposon mutants was extracted from 
each bacterial pellet with a Genomic DNA Purification Kit (Promega KK, Tokyo, Japan), according to the man-
ufacturer’s protocol. The total DNA was digested by HindIII (NEB, Tokyo, Japan), followed by heat inactivation 
of the restriction enzyme and self-ligation by Ligation high (TOYOBO, Osaka, Japan). The ligated DNA solution 
was used as the inverse PCR template. The inverse PCR was performed using KOD plus neo DNA polymerase 
(TOYOBO), using primers TNR-TAinvFw and TNR-TAinvRv (Supplementary Table 4), with the following pro-
gram: initial denaturation at 96 °C for 120 sec, 40 cycles of amplification (98 °C for 20 sec, 55 °C for 20 sec and 
68 °C for 45 sec) and extension at 68 °C for 5 min. Amplified products were purified by the Wizard SV Gel and 
PCR Clean-Up System (Promega KK), according to the manufacturer’s protocol. The purified DNA fragments 
and TNR-TAinvRv primers were used for sequencing. The sequencing reactions were performed using the Big 
Dye Terminator Cycle Sequencing system (Applied Biosystems, CA, USA) on an automated ABI 3100 sequencer 
(Applied Biosystems). The nucleotide sequence was submitted to a BLAST search of the genome sequence of 
BD7100 in the RAST server.
Resting-cell assay. Bacterial cells were grown at 30 °C with shaking for 16 h in 100 ml of LB medium con-
taining 0.5 mM BBR to make resting cells, which include enzymes induced by BBR. The cells were collected by 
centrifugation (2,610 × g, 15 min, room temperature), washed twice with 50 mM sodium phosphate buffer (pH 
7.0) and then suspended in 20 ml of 50 mM sodium phosphate buffer to yield a turbidity of 10 at 600 nm. Substrate 
was added to a final concentration of 0.5 mM, and the mixture of resting-cell suspension and substrate in the 
sodium phosphate buffer was incubated at 30 °C with shaking after adding the appropriate antibiotics. Aliquots of 
the reaction (0.4 ml/time point) were periodically removed, and the reaction was stopped (cells lysed, reactions 
quenched) by the addition of an equal volume of stop solution (MeOH containing 0.05 N HCl). After centrifuga-
tion at 18,800 × g at 4 °C for 10 min, the supernatants were analyzed by high-performance liquid chromatography 
(HPLC). HPLC conditions were described in a previous study11, 12.
Reverse transcription-polymerase chain reaction (RT-PCR). Bacterial cells were grown in 10 ml of 
LB or LB containing 0.5 mM BBR at 30 °C for 18 h with shaking. The cells were collected by centrifugation and 
washed three times with TE buffer. Total RNA was isolated using ISOGEN (Nippon gene, Tokyo, Japan), accord-
ing to the manufacturer’s protocol. RT-PCR was performed using the ReverTra Ace qPCR RT Master Mix with 
gDNA Remover (TOYOBO Co., Ltd., Osaka, Japan), as described in the manufacturer’s protocol. One microgram 
of total RNA was reverse-transcribed with random primers, and 32 cycles of PCR were performed (98 °C for 
20 sec, 55 °C for 20 sec and 68 °C for 45 sec) with the primer sets listed in Supplementary Table 4.
Complementation of brdA in TA140. To produce pTQbrdA, a NcoI-HindIII fragment PCR product 
was generated with primers CDS6194NcoFw and CDS6194HinRv (Supplementary Table 4) and cloned into the 
NcoI-HindIII site of pTip-QC1. pTip-QC1 and pTQbrdA were introduced into TA140 cells by electroporation 
(voltage: 1200 V, capacitance: 25 µF, resistance: 800 Ω, cuvette: 1 mm). Each transformant was precultured in 
LB medium containing 2 µg/ml thiostrepton and 30 µg/ml chloramphenicol. One milliliter of preculture was 
added to 100 ml of WM medium containing 5 µg/ml thiostrepton, 50 µg/ml chloramphenicol and 0.5 mM BBR 
or D-BBR and incubated at 30 °C with shaking. Growth was monitored using an OD monitor (TAITECH, Tokyo, 
Japan), and absorption was measured at 600 nm.
Expression of BrdA homologs with an N-terminal His-tag in E. coli. The cloning methods for con-
struction of pET system plasmids are described in the Supplementary Methods. Each plasmid was introduced 
into E. coli BL21 (DE3) by electroporation (voltage: 1800 V, capacitance: 25 µF, resistance: 200 Ω, cuvette: 1 mm), 
and the transformants were incubated in 100 ml of LB medium containing 25 µg/ml kanamycin at 15 °C, with 
shaking at 150 rpm. Isopropyl-β-D-thiogalactopyranoside (IPTG) (0.1 mM) was added to the culture when the 
OD600 of the culture reached 0.5. After 17 h of incubation, cells were collected by centrifugation and washed 
www.nature.com/scientificreports/
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in PBS buffer three times. Washed cells were suspended in PBS and ruptured by an ultrasonic cell disruptor. 
The solution was centrifuged at 18,800 × g for 10 min to separate the cell body and crude enzyme extract, and 
the supernatant was obtained as the crude extract, which contained His-BrdA. As a negative control, the crude 
extract without His-BrdA was prepared from cells of E. coli BL21 (DE3) harboring pET-28a ( + ) under the same 
conditions.
Crude-extract assay. The concentration of each protein was measured using a Qubit protein assay kit and 
Qubit 2.0 (Invitrogen, Carlsbad, CA, USA). The crude extract (1.2 mg of protein) was added to 0.5 mM substrate 
in 50 mM Tris-HCl buffer (pH 7.0) and incubated at 30 °C. Fifty microliters of reaction solution was collected at 
15-min intervals, and the reaction was stopped by adding an equal volume of stop solution. The amounts of BBR 
and D-BBR in the mixture were quantified by HPLC.
Purification of His-BrdA. His-BrdA proteins in the crude extract were purified using HisPurTM Ni-NTA 
Resin (Thermo Fisher Scientific, Yokohama, Japan), according to the manufacturer’s protocol, and the sam-
ple in the elution buffer was exchanged into 50 mM Tris-HCl buffer using a Microcon centrifugal filter device 
(Millipore, Bedford, MA, USA). The concentration of purified proteins was measured using a Qubit protein assay 
kit and Qubit 2.0 (Invitrogen, Carlsbad, CA, USA). The expression and purity of each His-BrdA protein were 
assessed by SDS-PAGE.
Purified-enzyme assay. The assay was performed in 500 µl of 50 mM Tris-HCl buffer (pH 7.0) containing 
10 µg of His-BrdA, 0.5 mM BBR and 2 mM THF. THF was dissolved in a solution containing 0.5 mM Tris-HCl 
buffer (pH 9.0), 1% (v/v) 2-mercaptoethanol and 2% (w/v) ascorbate. The reaction was stopped by adding an 
equal volume of stop solution. The concentrations of BBR and D-BBR were analyzed by HPLC.
Isolation of BBR-utilizing bacteria. A piece of root from Coptis japonica (15 mm) with soil was added 
directly to 3 ml of WM medium containing 0.5 mM BBR and incubated at 30 °C for 6 days in a shaker. An ali-
quot of the resulting culture was diluted 1:100 into 3 ml of fresh WM medium containing 0.5 mM BBR, and the 
dilution was incubated at 30 °C for 6 days on a rotary shaker. This 1:100 dilution and outgrowth was repeated 
twice more (for a total of three times). An aliquot of the resulting culture was spread directly onto a plate of WM 
medium agar containing 0.5 mM BBR.
Identification of BBR-utilizing bacteria. Total DNA of BD3100 and BD7100 was extracted using a 
Genomic DNA Purification Kit (Promega KK, Tokyo, Japan), according to the manufacturer’s protocol. The 16 S 
rDNA was amplified using the 27 F and 1525 R primer pair (Supplementary Table 4). PCR was performed using 
KOD plus neo DNA polymerase (TOYOBO, Osaka, Japan) with the following program: initial denaturation at 
96 °C for 120 sec, 34 cycles of amplification (94 °C for 20 sec, 55 °C for 20 sec and 68 °C for 45 sec) and extension at 
68 °C for 5 min. Amplified products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega 
KK). The purified DNA fragments were used a template for sequencing reactions, which were performed with 
27 F or 1525 R primers using the Big Dye Terminator Cycle Sequencing system (Applied Biosystems, CA, USA) 
on an automated ABI 3100 sequencer (Applied Biosystems). The 16 S rDNA gene sequences of the isolated bacte-
ria were submitted to the classifier program in the Ribosomal Database Project, release 11.3, which is maintained 
by the Center for Microbial Ecology at Michigan State University (http://rdp.cme.msu.edu/)23.
Construction of deletion mutants of BD3100 by homologous recombination. The deletion 
mutants of target genes were constructed by double crossover using pK18mobsacB. Details of the construction 
of pK18∆1201 and pK18∆1137 are described in the Supplementary Methods. The plasmids pK18∆1201 and 
pK18∆1137, derived from pK18mobSacB, were electroporated into BD3100. The transformants were selected 
on LB plates containing 50 µg/ml of kanamycin. To make a double-crossover mutant, the sucrose-sensitive trans-
formants were selected and incubated in LB for 12 h. The sucrose-resistant mutants were selected on LB plates 
containing 10% sucrose. The mutants that showed the sucrose-resistant and kanamycin-sensitive phenotype were 
candidates for deletion mutants. The gene deletion was confirmed by Southern hybridization (Supplementary 
Fig. 12). To make 1202 and 1138 probes, PCR was carried out using the 1202 F and 1202 R primer set and the 
1138 F and 1138 R primer set, respectively (Supplementary Table 4). The labeling of PCR products and Southern 
hybridization were performed using a DIG-High Prime DNA Labeling and Detection Starter Kit (Roche), accord-
ing to the manufacturer’s protocol.
Data Availability. The nucleotide sequences reported in this study have been deposited in the International 
Nucleotide Sequence Database Collaboration under Accession No. LC214531 for 16 S rRNA of GBD-1, LC214532 
for 16 S rRNA of CJ1, LC214741 for brdA of BD7100, LC214742 and LC214743 for brdA1 and brdA2 of BD3100, 
respectively, LC214744 and LC214745 for brdA and CDS4435 of GBD-1 and LC214746 and LC214747 for brdA1 
and brdA2 of CJ1.
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